Patel Sanj K

Average Profitability
<0.0001%
Insider Buys Quantity
1
Insider Buys Sum
$999,982.98
Insider Sells Quantity
11
Insider Sells Sum
$21.68M

Insider Activity of Patel Sanj K

According to the SEC Form 4 filings, Patel Sanj K, being in a position of

  1. CHAIRMAN & CEO at Kiniksa Pharmaceuticals, Ltd.,
    оver the last 12 months, has bought 0 shares, and sold 225685 shares for $5.55M,
    over all time since 2018-02-09, has bought 127844 shares for $999,983, and sold 990713 shares for $21.68M.

The largest purchase of all time was on 2018-02-09 and amounted to 127844 shares of Kiniksa Pharmaceuticals, Ltd. for $999,983.

The largest sale of all time was on 2020-10-12 and amounted to 500060 shares of Kiniksa Pharmaceuticals, Ltd. for $10.51M.

Biography of Patel Sanj K

No biography is available at this moment.

Statistics of Insider Transactions Last Year

Amount of Insider Buys and Sells by Stocks

Buys
$000
Sells
$5,551,8502100

Comparison of Insiders on Amount of Buys and Sells

2024-11-06SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHAIRMAN & CEO
89,561
0.1239%
$23.00$2.06M-11.9%
2024-07-23SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHAIRMAN & CEO
136,124
0.1877%
$25.65$3.49M-15.1%
2024-03-07SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHAIRMAN & CEO
65,012
0.0919%
$21.02$1.37M-4.4%
2024-03-06SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHAIRMAN & CEO
5,582
0.008%
$21.00$117,222-3.21%
2024-03-04SaleKiniksa Pharmaceuticals, Ltd.
KNSA
CHAIRMAN & CEO
12,742
0.0194%
$21.49$273,834+0.62%
2021-02-10SaleKiniksa Pharmaceuticals, Ltd.
KNSA
Chairman & CEO
5,474
0.0085%
$23.06$126,253-38.71%
2021-02-09SaleKiniksa Pharmaceuticals, Ltd.
KNSA
Chairman & CEO
87,940
0.1324%
$23.06$2.03M-40.33%
2021-02-08SaleKiniksa Pharmaceuticals, Ltd.
KNSA
Chairman & CEO
18,904
0.0209%
$17.42$329,369-41.64%
2020-10-12SaleKiniksa Pharmaceuticals, Ltd.
KNSA
Chairman & CEO
500,060
0.8036%
$21.02$10.51M-25.98%
2020-10-09SaleKiniksa Pharmaceuticals, Ltd.
KNSA
Chairman & CEO
3,084
0.0037%
$15.51$47,838-25.06%
2020-03-06SaleKiniksa Pharmaceuticals, Ltd.
KNSA
Chairman & CEO
66,230
0.1212%
$20.00$1.32M-3.85%
2018-02-09PurchaseKiniksa Pharmaceuticals, Ltd.
KNSA
Chairman & CEO
127,844
$7.82$999,983-0.44%
Total: 12
*Some uncertain data for Preferred Stock share type transactions are shown in italics; for actual data please follow the link
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.